Jump to main navigation Skip to Content

DFG Logo: back to Homepage Deutsche Forschungsgemeinschaft

banner: Kopfbereich DFG2020 Logo - englisch Because research matters

Professor Dr. Britta Siegmund

Vice President of the DFG since 2019

Professor Dr. Britta Siegmund

Professor Dr. Britta Siegmund

Born 25 October 1971

Britta Siegmund is Medical Director of the Medical Department, Division of Gastroenterology, Infectiology and Rheumatology, Charité – Universitätsmedizin Berlin.

Education

YearDescription
1992 - 1998Study of Medicine, Ludwig-Maximilians-Universität München
and Harvard Medical School, Boston
2007Board certificate in Internal Medicine
2009Board certificate in Gastroenterology

Academic degrees

YearDescription
1998Doctorate, Dr. med., Department of Clinical Pharmacology, Ludwig-Maximilians-Universität München (Prof. Dr. S. Endres)
2006Habilitation, venia legendi, Charité - Universitätsmedizin Berlin (Prof. Dr. M. Zeitz)

Professional and academic career

YearDescription
Since 3/2016Medical Director, Charité Center 13
(Gastroenterology, Nephrology, Metabolic Diseases)
Since 2013W3 professor, Medical Director of the Medical Department, Division of Gastroenterology, Infectiology and Rheumatology,
Benjamin Franklin Campus, Charité - Universitätsmedizin Berlin
2012 - 2013Acting Head of Division, Medical Department, Division of Gastroenterology, Infectiology and Rheumatology,
Benjamin Franklin Campus, Charité - Universitätsmedizin Berlin
2012 - 2013W2 Heisenberg professorship, "Translational Gastroenterology – Inflammatory Bowel Disease"; Charité – Universitätsmedizin Berlin
2007 - 2012Senior physician, Medical Department, Division of Gastroenterology, Infectiology and Rheumatology,
Benjamin Franklin Campus, Charité - Universitätsmedizin Berlin
2002 - 2007Residency in internal medicine, Medical Department, Division of Gastroenterology, Infectiology and Rheumatology,
Benjamin Franklin Campus, Charité – Universitätsmedizin Berlin
2000 - 20022000-2002 DFG research fellowship, Department
of Infectious Diseases, University of Colorado, Denver, CO, USA
(Prof. C. A. Dinarello)
1998 - 2000Residency, Department of Medicine, Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität, München
(Prof. Dr. Dr. h.c. P. Scriba)

Other activities

YearDescription
Since 2019Head of Clinical Translational Science Platform (CTP) at the Berlin Institute of Health
Since 2018Member of spokesperson committee for the advisory board of the German Crohn’s & Colitis Association (DCCV)
Since 2018Co-spokesperson of CRC/Transregio 241 “Immune-Epithelial Communication in Inflammatory Bowel Diseases”
(Erlangen, Berlin)
Since 2018Member of the Advisory Board of EBioMedicine & Nature Review in Gastroenterology & Hepatology
Since 2017Member of DFG Senate
Since 2017Chair of Berlin-Brandenburg Society of Gastroenterology and Hepatology
Since 2017Board member of the German Society of Gastroenterology and Digestive and Metabolic Diseases (DGVS)
Since 2017Member of Scientific Committee of United European Gastroenterology (UEG)
Since 2016Member of the supervisory board of the Berlin Institute of Health
2016 - 2017Member of DFG review board
Since 2016Member of the committee of the United Registries for Clinical Assessment and Research (UR-CARE), European Crohn’s & Colitis Organization (ECCO)
Since 2016Member of Leibniz ScienceCampus Berlin on chronic inflammation
2015 - 2016Member of the advisory board of DGVS
Since 2015Associate Editor, Journal of Crohn’s and Colitis
2014 - 2018Member of the advisory board of DCCV
2016 - 2018Member of the research committee of the Berlin Institute of Health
Since 2015Member of the supervisory board of Universitätsmedizin Münster, Germany
2014 - 2017Member and, in 2017, chair of the ECCO Scientific Committee
2013 - 2018ECCO National Representative
2012 - 2015Spokesperson for CRC 633 “Induction and Modulation of T cell Mediated Immune Responses in the Gastrointestinal Tract”
Since 2012Board member of Intestinal Diseases Network
Since 2010Deputy director of Clinician Scientist Program at the Berlin Institute of Health and Charité – Universitätsmedizin Berlin
Since 2009Member of the spokesperson committee of the German IBD Study Group
Since 2009Faculty member of the International Max Planck Research School for Infectious Diseases and Immunology
2009Chair of German Work Group for Inflammatory Bowel Diseases
2008 - 2012Scientific Secretary of CRC SFB 633 “Induction and Modulation of T cell Mediated Immune Responses in the Gastrointestinal Tract”
2005 - 2001Member of Research Committee, Charité – Universitätsmedizin Berlin

Awards

YearDescription
1997Fellowship from the Harvard-Munich Alliance for Medical Education
2000DFG research fellowship
2002Fellowship for Keystone Symposium “Microbial-Epithelial-Lymphocyte Interactions in Mucosal Immunity”
2003 - 2007DFG Emmy Noether independent junior research group
2006Rising Star in Gastroenterology, United European Gastroenterology Federation
2012DFG Heisenberg professorship
Since 2017Member of the German National Academy of Sciences Leopoldina
Since 2019Member of the Berlin-Brandenburg Academy of Sciences and Humanities

Reviewer roles

Journals

American Journal of Pathology, Biochemical Pharmacology, BMC Gastroenterology, Cancer Letters, Cell & Tissue Research, Current Pharmaceutical Design, Deutsches Ärzteblatt, AP&T, Cell, Cell Metabolism, Cell Reports, Digestion, EMBO Molecular Medicine, Experimental and Clinical Endocrinology & Diabetes, Expert Reviews Immunology, Gastroenterology, Gut, Human Immunology, Human Pathology, Immunity, Inflammatory Bowel Diseases, International Journal of Colorectal Diseases, Journal of Crohn’s and Colitis, Journal of Immunology, Journal of Inflammation, Journal of Molecular Medicine, Lancet, Lancet Gastroenterology & Hepatology, Medizinische Klinik, Nature Reviews in Immunology, Nature Immunology, Nature Communication, Nature Medicine, eLife, PLoS One, Proceedings of the National Academy of Sciences USA, Trends in Immunology, Zeitschrift fur Gastroenterologie

Funding organisations

Agence Nationale de la Recherche, BONFOR Programme, University of Bonn, Crohn’s & Colitis Foundation of America, Czech Health Research Council, Deutsche Forschungsgemeinschaft (DFG), Deutsche Krebshilfe (German Cancer Aid), Ethikkommission Wien, European Crohn’s & Colitis Organization, European Research Council, Elis & Edythe Broad Foundation, Flanders Research Foundation, German-Israeli Foundation, INSERM, International Organization for the Study of IBD, Max Rubner Prize, UK Medical Research Council, Netherlands Organisation of Scientific Research (NWO); Research Foundation Flanders, United States – Israel Binational Science Foundation, Swiss National Science Foundation

Memberships

Berlin-Brandenburg Society of Gastroenterology and Hepatology,Berlin-Brandenburg Academy of Sciences and Humanities, German Association of University Professors and Lecturers, German Society of Internal Medicine, German Society of Gastroenterology and Digestive and Metabolic Diseases, German Society of Transition Medicine, European Crohn’s and Colitis Organisation, Intestinal Diseases Network, German National Academy of Sciences Leopoldina, Society of Mucosal Immunology

Third-party funding

YearDescription
2003 - 2007DFG Emmy Noether Programme, SI 749/3-1, SI 749/3-3, SI 749/3-4
2004 - 2006Elis and Edythe Broad Foundation
2006 - 2013SI 749/5-1; SI 749/5-3
2007 - 2011CRC 633, project A12N
2006 - 2009BMBF, Inflammatory Bowel Disease Network
2011 - 2015CRC 633, project A12, ZP01
2012 - 2015DFG Heisenberg professorship, DFG SI 749/6-1
2015Stiftung Charité, BIH_PRO-318
2013 - 2016Helmholtz, Preclinical Comprehensive Cancer Center
2013 - 2016PP 1658 „Intestinal Microbiota“, SI 749/7-1
2015 - 2020Horizon 2020, SPARE Project (national coordinator)
2015 - 2020German-Israel Foundation, I-1295-414
2016 - 2019Deutsche Krebshilfe (German Cancer Aid), 70112011
2016 - 2020DFG, SI 749/10-1
2016 - 2019Berlin Institute of Health, „GESPIC-Crohn”-study
2016 - 2029SPP 1658 „Intestinal Microbiota“, Si 749/9-1
2017 - 2020DFG, GRK 2318 “Tight Junction Train”
2018 - 2022DFG, CRC-TRR 241 “Immune-Epithelial Communication in IBD”, B02, Z01
2018 - 2022DFG, CRC 1340 “Matrix in Vision“, B06